1 document found, page 1 of 1

Sort by Issue Date
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

Translating Results From the Cardiovascular Outcomes Trials with Glucagon-Like ...

Janez, A; Muzurovic, E; Stoian, A; Haluzik, M; Guja, C; Czupryniak, L; Duvnjak, L; Lalic, N; Tankova, T; Bogdanski, P; Papanas, N; Silva Nunes, J

Glucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of the endogenous GLP-1 incretin hormone, improving glycaemic control in type 2 diabetes mellitus (T2DM) by increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner. However, as cardiovascular (CV) morbidity and mortality is common in patients with T2DM, several trials with the use of GLP-1 receptor agonists (...

Date: 2022   |   Origin: Repositório do Centro Hospitalar de Lisboa Central, EPE
More info.
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

1 Results

Queried text

Refine Results

Author
















Date


Document Type


Access rights


Resource


Subject